BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1445434)

  • 1. [The mechanism of anticholinesterase action of acetylene organophosphorus inhibitors].
    Brestkin AP; Zhukovskiĭ IuG; Moralev SN; Rozengart VI; Sochilina EE; Iagodina OV; Vikhreva LA; Godovikov NN; Kabachnik MI
    Bioorg Khim; 1992 Aug; 18(8):1067-72. PubMed ID: 1445434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of the "acetylene effect" during interaction of organophosphorus compounds with cholinesterases].
    Kabachnik MI; Godovikov NN; Vikhreva LA; Pudova TA; Brestkin AP; Rozengart VI
    Izv Akad Nauk Ser Biol; 1999; (5):517-26. PubMed ID: 10581870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major intermediates in organophosphate synthesis (PCl3, POCl3, PSCl3, and their diethyl esters) are anticholinesterase agents directly or on activation.
    Segall Y; Quistad GB; Sparks SE; Casida JE
    Chem Res Toxicol; 2003 Mar; 16(3):350-6. PubMed ID: 12641435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of substituted thiobutinylic esters of phosphorus thio acids and their saturated analogs on cholinesterases of different origins].
    Balashova EK; Brestkin AP; Vikhreva LA; Godovikov NN; Kabachnik MI
    Zh Evol Biokhim Fiziol; 1982; 18(4):325-9. PubMed ID: 7124204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biochemical characteristics of aminostigmine--a new anticholinesterase agent].
    Prozorovskiĭ VB; Rozengart VI; Ardab'eva TV; Kugusheva LI; Suslova IM
    Biokhimiia; 1996 Apr; 61(4):690-6. PubMed ID: 8724787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interaction of dialkyl(alpha-carbomethoxy-beta,beta,beta-trifluoro- ethyl) phosphates with mammalian esterases].
    Makhaeva GF; Fetisov VI; Sokolov VB; Iankovskaia VL; Goreva TV
    Bioorg Khim; 1987 Jan; 13(1):33-7. PubMed ID: 3566818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase.
    Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F
    Toxicology; 2006 Jul; 224(1-2):91-9. PubMed ID: 16720069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthesis and anticholinesterase activity of acetylene organophosphorus compounds].
    Balashova EK; Brestkin AP; Zhukovskiĭ IuG; Rozengart VI; Sherstobitov OE
    Dokl Akad Nauk SSSR; 1983; 272(2):503-6. PubMed ID: 6679836
    [No Abstract]   [Full Text] [Related]  

  • 9. [Formation of models of the interaction between organophosphate compound structure and their ability to inhibit cholinesterase].
    Raevskiĭ OA; Chistiakov VV; Agabekian RS; Sapegin AM; Zefirov NS
    Bioorg Khim; 1990 Nov; 16(11):1509-22. PubMed ID: 2096825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Finding cholinesterase in endotheliocytes: cholinesterase inhibition by organophosphorus compounds leads to endotheliocyte deformation].
    Prozorovskiĭ VB; Skopichev VG
    Eksp Klin Farmakol; 2005; 68(3):64-7. PubMed ID: 16047685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain cholinesterases. Differentiation of target enzymes for toxic organophosphorus compounds.
    Chemnitius JM; Haselmeyer KH; Zech R
    Biochem Pharmacol; 1983 Jun; 32(11):1693-9. PubMed ID: 6870909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Catalytic properties of the acetylcholinesterase from human erythrocytes].
    Abramovich TD; Borzunina AM; Golub TL; Eremeeva AM; Zhukovskiĭ IuG
    Biokhimiia; 1973; 38(6):1137-43. PubMed ID: 4802004
    [No Abstract]   [Full Text] [Related]  

  • 13. Design and structure-activity relationships of antidotes to organophosphorus anticholinesterase agents.
    Gray AP
    Drug Metab Rev; 1984; 15(3):557-89. PubMed ID: 6386410
    [No Abstract]   [Full Text] [Related]  

  • 14. [Restoration of acetylcholinesterase activity in animals intoxicated with pinacolyl-methylphosphonofluoridate].
    Faff J
    Acta Physiol Pol; 1972; 23(4):685-95. PubMed ID: 5080267
    [No Abstract]   [Full Text] [Related]  

  • 15. Degradation of nerve agents by an organophosphate-degrading agent (OpdA).
    Dawson RM; Pantelidis S; Rose HR; Kotsonis SE
    J Hazard Mater; 2008 Sep; 157(2-3):308-14. PubMed ID: 18258361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters.
    Masson P; Nachon F; Broomfield CA; Lenz DE; Verdier L; Schopfer LM; Lockridge O
    Chem Biol Interact; 2008 Sep; 175(1-3):273-80. PubMed ID: 18508040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The cholinesterase reactivity of the Komandor squid Berryteuthis magister. Substrates and organophosphorus inhibitors].
    Rozengart EV
    Zh Evol Biokhim Fiziol; 1996; 32(5):576-83. PubMed ID: 9092237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring exposure of passerines to acephate, dicrotophos, and malathion using cholinesterase reactivation.
    Maul JD; Farris JL
    Bull Environ Contam Toxicol; 2004 Oct; 73(4):682-9. PubMed ID: 15389333
    [No Abstract]   [Full Text] [Related]  

  • 19. [Kinetics of hydrolysis of the phenyl analog of acetylcholine under the action of cholinesterase from horse serum and acetylcholinesterase from bovine erythrocytes].
    Brestkin AP; Brik IL; Teplov NE
    Biokhimiia; 1968; 33(5):1059-68. PubMed ID: 5703735
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of environment on allosteric properties of acetylcholinesterase].
    Freĭdlin TS; Balashova EK; Rozengart VI; Sherstobitov OE
    Biokhimiia; 1977 Sep; 42(9):1626-30. PubMed ID: 20999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.